Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v6-EN
Language French English
Date Updated 2018-01-09 2018-01-09
Drug Identification Number 02382636 02382636
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10 HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10
Common or Proper name HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10X1ML 10X1ML
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2017-11-08 2017-11-08
Estimated end date
Actual end date 2017-12-29 2017-12-29
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions. Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.
Health Canada comments